Tsai, M., Lin, Y., Chen, D., Lin, M., Wang, C., Hsieh, I., . . . Chen, T. (2024). Ticagrelor versus Adjusted‐Dose Prasugrel in Acute Coronary Syndrome with Percutaneous Coronary Intervention. Clinical pharmacology and therapeutics, 116(3), 747-756. https://doi.org/10.1002/cpt.3209
Chicago-Zitierstil (17. Ausg.)Tsai, Ming‐Lung, Yuan Lin, Dong‐Yi Chen, Ming‐Shyan Lin, Chao‐Yung Wang, I‐Chang Hsieh, Ning‐I Yang, Ming‐Jui Hung, und Tien‐Hsing Chen. "Ticagrelor Versus Adjusted‐Dose Prasugrel in Acute Coronary Syndrome with Percutaneous Coronary Intervention." Clinical Pharmacology and Therapeutics 116, no. 3 (2024): 747-756. https://doi.org/10.1002/cpt.3209.
MLA-Zitierstil (9. Ausg.)Tsai, Ming‐Lung, et al. "Ticagrelor Versus Adjusted‐Dose Prasugrel in Acute Coronary Syndrome with Percutaneous Coronary Intervention." Clinical Pharmacology and Therapeutics, vol. 116, no. 3, 2024, pp. 747-756, https://doi.org/10.1002/cpt.3209.